Triclosan inhibits tumor necrosis factor-α-stimulated urokinase production in human gingival fibroblasts

Journal of Periodontal Research

Volumn 44, Issue 6, 2009, Pages 726-735

  Arancibia, R ^a   Caceres M ^b   Martinez J ^b   Smith, P C ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Fibroblast; Gingival; Triclosan; Urokinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTHRA(1,9 CD)PYRAZOL 6(2H) ONE; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; ENZYME INHIBITOR; FLAVONOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PEPTIDE; PLASMIN; PLASMINOGEN; SERINE PROTEINASE INHIBITOR; SN 50; STRESS ACTIVATED PROTEIN KINASE; TRICLOSAN; TUMOR NECROSIS FACTOR ALPHA; UROKINASE;

ARTICLE; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FIBROBLAST; GINGIVA; HUMAN; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANTHRACENES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FIBRINOLYSIN; FIBROBLASTS; FLAVONOIDS; GINGIVA; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 1; NF-KAPPA B; PEPTIDES; PHOSPHORYLATION; PLASMINOGEN; RNA, MESSENGER; SERINE PROTEINASE INHIBITORS; SIGNAL TRANSDUCTION; TRICLOSAN; TUMOR NECROSIS FACTOR-ALPHA; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 70350508720     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2008.01184.x     Document Type: Article

References (43)

1. Saxton CA. Maintenance of gingival health by a dentifrice containing zinc citrate and triclosan. J Dent Res 1989 68 : 1724 1726.
2. Stephen KW, Saxton CA, Jones CL, Ritchie JA, Morrison T. Control of gingivitis and calculus by a dentifrice containing a zinc salt and triclosan. J Periodontol 1990 61 : 674 679.
3. Lindhe J, Rosling B, Socransky SS, Volpe AR. The effect of triclosan containing dentifrice on established plaque and gingivitis. J Clin Periodontol 1993 20 : 327 334.
4. Ellingsen JE, Rölla G. Dental plaque inhibition by a combination of triclosan and polydimethylsiloxane (silicone oil). Scand J Dent Res 1994 102 : 26 29.
5. Kanchanakamol U, Umpriwa R, Jotikasthira N et al. Reduction of plaque formation and gingivitis by a dentifrice containing triclosan and copolymer. J Periodontol 1995 66 : 109 112.
6. Niederman R. Triclosan-containing toothpastes reduce plaque and gingivitis. Evid Based Dent 2005 6 : 33.
7. Müller HP, Barrieshi-Nusair KM, Könönen E, Yang M. Effect of triclosan-copolymer-containing toothpaste on the association between plaque and gingival bleeding: a randomized controlled clinical trial. J Clin Periodontol 2003 33 : 811 818.
8. Skaare A, Eide G, Herlofson B, Barkvoll P, Rölla G. The effect of toothpaste containing triclosan on oral mucosal desquamation. J Clin Periodontol 1996 23 : 1100 1103. (Pubitemid 126732086)
9. Barkvoll P, Rölla G. Triclosan protects the skin against dermatitis caused by sodium lauryl sulphate exposure. J Clin Periodontol 1994 21 : 717 719.
10. Gaffar A, Scherl D, Afflitto J, Coleman EJ. The effect of triclosan on mediators of gingival inflammation. J Clin Periodontol 1995 22 : 480 484.
11. Modéer T, Bengtsson A, Rölla G. Triclosan reduces prostaglandin biosynthesis in human gingival fibroblasts challenged with interleukin-1 in vitro. J Clin Periodontol 1996 23 : 927 933.
12. Mustafa M, Wondimu B, Yucel-Lindberg T, Kats A-Hallström T, Jonsson AS, Modéer T. Triclosan reduces microsomal prostaglandin E synthase-1 expression in human gingival fibroblasts. J Clin Periodontol 2005 32 : 6 11.
13. Furuichi Y, Rosling B, Volpe AR, Lindhe J. The effect of a triclosan-copolymer dentifrice on healing after non-surgical treatment of recurrent periodontitis. J Clin Periodontol 1999 26 : 63 66.
14. Kerdvongbundit V, Wikesjö UM. Effect of triclosan on healing following non-surgical periodontal therapy in smokers. J Clin Periodontol 2003 30 : 1024 1030.
15. Ellwood RP, Worthington HV, Blinkhorn AS, Volpe AR, Davies RM. Effect of a triclosan-copolymer dentifrice on the incidence of periodontal attachment loss in adolescents. J Clin Periodontol 1998 25 : 363 367.
16. Rosling B, Dahlén G, Volpe A, Furuichi Y, Ramberg P, Lindhe J. Effect of triclosan on the subgingival microbiota of periodontitis-susceptible subjects. J Clin Periodontol 1997 24 : 881 887.
17. Cullinan MP, Westerman B, Hamlet SM, Palmer JE, Faddy MJ, Seymour GJ. The effect of a triclosan-containing dentifrice on the progression of periodontal disease in an adult population. J Clin Periodontol 2003 30 : 414 419.
18. Rosling B, Wannfors B, Volpe AR, Furuichi Y, Ramberg P, Lindhe J. The use of a triclosan-copolymer dentifrice may retard the progression of periodontitis. J Clin Periodontol 1997 24 : 873 880.
19. Hannas AR, Pereira JC, Granjeiro JM, Tjäderhane L. The role of matrix metalloproteinases in the oral environment. Acta Odontol Scand 2007 65 : 1 13.
20. Bartold PM, Walsh LJ, Narayanan AS. Molecular and cell biology of the gingiva. Periodontol 2000 2000 24 : 28 55.
21. Danø K, Andreasen PA, Grondhal-Hansen K, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 1985 44 : 139 266.
22. Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodontal Res 1993 28 : 500 510.
23. Smith P, Morales JP, Santibáñez JF, Martínez J. Epidermal growth factor (EGF) stimulates urokinase expresión in human gingival fibroblasts. Possible modulation by Genistein and Curcumin. J Periodontal Res 2004 39 : 380 387.
24. Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ 2003 10 : 45 65.
25. Rossomando EF, Kennedy JE, Hadjimichael J. TNF-α in gingival crevicular fluid as a possible disease in humans. Arch Oral Biol 1990 35 : 431 434.
26. Roberts FA, McCaffery KA, Michalek SM. Profile of cytokine mRNA expression in chronic adult periodontitis. J Dent Res 1997 76 : 1833 1839.
27. Larjava H, Heino J, Kähäri V-M, Vuorio E. Characterization of one phenotype of human periodontal granulation-tissue fibroblasts. J Dent Res 1989 68 : 20 25.
28. Cáceres M, Tobar N, Guerrero J, Smith PC, Martínez J. c-jun-NH2JNK mediates invasive potential and EGFR activation by regulating the expression of HB-EGF in a urokinase-stimulated pathway. J Cell Biochem 2008 103 : 986 993.
29. Santibañez JF, Maccioni RB, Martínez J. The secretion of urokinase-like plasminogen activator is inhibited by microtubule-interacting drugs. Cell Biochem Funct 1995 13 : 217 225.
30. Sliva D, Rizzo MT, English D. Phosphatidylinositol 3-Kinase and NFκβ Regulate Motility of Invasive MDA-MB-231 Human Breast Cancer Cells by the Secretion of Urokinase-type Plasminogen Activator. J Biol Chem 2002 277 : 3150 3157.
31. Lin YZ, Yao SY, Veach RA, Torgerson TR, Hawiger J. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 1995 270 : 14255 14258.
32. Curtin JF, Cotter TG. (2004) JNK regulates HIPK3 expression and promotes resistance to Fas-mediated apoptosis in DU 145 prostate carcinoma cells. J Biol Chem 2004 279 : 17090 17100.
33. Heasman PA, Collins JG, Offenbacher S. Changes in crevicular fluid level of Interleukin-1 beta, leukotriene B4, prostaglandin E2, and tumor necrosis factor alpha in experimental gingivitis in man. J Periodontal Res 1993 28 : 241 247.
34. Westwick JK, Weitzel C, Mindenn A, Karinn M, Brenner DA. Tumor Necrosis Factor-α stimulates AP-1 activity through prolonged activation of the c-Jun Kinase. J Biol Chem 1994 269 : 26396 26401.
35. Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T. Increase of CCL20 expression by human gingival fibroblasts upon stimulation with cytokines and bacterial endotoxin. Clin Exp Immunol 2005 142 : 285 291.
36. Han Z, Boyle DL, Chang L et al. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 2001 108 : 73 81.
37. Fan C, Li Q, Zhang Y et al. κBα and IκBβ possess injury context-specific functions that uniquely influence hepatic NF-κB induction and inflammation. J Clin Invest 2004 113 : 746 755.
38. Papa S, Zazzeroni F, Pham CG, Bubici C, Franzoso G. Linking JNK signaling to NF-kB: a key to survival. J Cell Sci 2004 117 : 5197 5208.
39. Kim YJ, Rossa C Jr., Kirkwood KL. Prostaglandin production by human gingival fibroblasts inhibited by triclosan in the presence of cetylpyridinium chloride. J Periodontol 2005 76 : 1735 1742.
40. Karin M. Nuclear factor-κβ in cancer development and progression. Nature 2005 441 : 431 436.
41. Efer R, Wagner EF. AP-1: a double-edge sword in tumorigenesis. Nat Rev Cancer 2003 3 : 859 867.
42. Heitz-Mayfield LJ. Disease progression: identification of high-risk groups and individuals for periodontitis. J Clin Periodontol 2005 32 : 196 209.
43. Schäfer BM, Maier K, Eickhoff U, Todd RF, Kramer MD. Plasminogen activation in healing human wounds. Am J Pathol 1994 144 : 1269 1280.